HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mor Oron-Herman Selected Research

1-formylcyclopropane-2-carboxylic acid (CPSSA)

12/2005The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mor Oron-Herman Research Topics

Disease

6Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2014 - 11/2003
5Neoplasms (Cancer)
01/2019 - 01/2012
5Hypertension (High Blood Pressure)
09/2008 - 11/2003
4Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 05/2008
4Fatty Liver
12/2014 - 05/2005
4Hypertriglyceridemia
09/2008 - 11/2003
3Non-alcoholic Fatty Liver Disease
12/2014 - 08/2010
3Hyperinsulinism (Hyperinsulinemia)
09/2008 - 11/2003
2Colonic Neoplasms (Colon Cancer)
01/2019 - 05/2008
2Fibrosis (Cirrhosis)
08/2010 - 05/2005
2Body Weight (Weight, Body)
05/2008 - 03/2005
2Weight Gain
03/2005 - 12/2003
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2016
1Carcinoma (Carcinomatosis)
07/2013
1Hypercholesterolemia
09/2008
1Insulin Resistance
09/2008
1Glucose Intolerance
09/2008
1Hypoadiponectinemia
02/2007
1Obesity
03/2005
1Weight Loss (Weight Reduction)
12/2003
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2003
1Hyperhomocysteinemia
11/2003

Drug/Important Bio-Agent (IBA)

10FructoseIBA
12/2014 - 11/2003
5Triglycerides (Triacylglycerol)IBA
12/2014 - 03/2005
4Captopril (Capoten)FDA LinkGeneric
03/2008 - 03/2005
3Antihypertensive Agents (Antihypertensives)IBA
12/2014 - 03/2005
3Rosiglitazone (Avandia)FDA Link
08/2010 - 03/2005
3Insulin (Novolin)FDA Link
09/2008 - 11/2003
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2016 - 05/2008
2ErbB Receptors (EGF Receptor)IBA
07/2013 - 01/2012
2Epidermal Growth Factor (EGF)IBA
07/2013 - 01/2012
2Pharmaceutical PreparationsIBA
05/2008 - 03/2005
2allicinIBA
12/2005 - 12/2003
1Cathepsin BIBA
01/2019
1ferric oxide (iron oxide)IBA
10/2017
1Peptides (Polypeptides)IBA
10/2017
1Somatostatin Receptors (Somatostatin Receptor)IBA
10/2016
1methacrylic acidIBA
10/2016
1PolymersIBA
10/2016
1CopperIBA
12/2014
1Monoclonal AntibodiesIBA
01/2012
1Sucrose (Saccharose)IBA
09/2008
1Amlodipine (Norvasc)FDA LinkGeneric
03/2008
1BezafibrateIBA
03/2008
1PPAR-gamma AgonistsIBA
02/2007
1AdiponectinIBA
02/2007
11-formylcyclopropane-2-carboxylic acid (CPSSA)IBA
12/2005
1CholesterolIBA
05/2005
1Phospholipids (Phosphatides)FDA LinkGeneric
05/2005
1LipidsIBA
03/2005
1Glucose (Dextrose)FDA LinkGeneric
03/2005
1HomocysteineIBA
03/2005
1CarbohydratesIBA
12/2003
1PotassiumIBA
12/2003
1Proteins (Proteins, Gene)FDA Link
12/2003
1SodiumIBA
12/2003

Therapy/Procedure

1Therapeutics
01/2019